Integrin α6 emerges to be a diagnostic biomarker for hepatocellular carcinoma (HCC). Here,
we translated our previously identified integrin α6 targeted peptide RWY into a positron …

Introduction Integrin α6 is an attractive diagnostic biomarker for molecular imaging of
hepatocellular carcinoma (HCC) as it has an extremely high positive rate (approximately …

Purpose Magnetic resonance imaging (MRI) has a high spatial resolution for detecting
hepatocellular carcinoma (HCC). Integrin α6 has emerged as a diagnostic and prognostic …

Colorectal cancer (CRC) is the third most common cancer and the fourth leading cause of
cancer deaths worldwide. Integrin α6 is overexpressed in all stages of CRC which makes it a …

Purpose Hepatocellular carcinoma (HCC) is a highly vascularized solid carcinoma and
tumor vessel–targeted molecular imaging might be effective for early diagnosis of HCC …

Integrin αvβ6 is a cell surface receptor minimally expressed by healthy tissue but elevated in
lung, colon, skin, ovarian, cervical, and pancreatic cancers. A molecular PET agent for …

The overexpression of integrin αvβ6 in pancreatic cancer makes it a promising target for
noninvasive PET imaging. However, currently, most integrin αvβ6–targeting radiotracers are …

Dear Editor, Recently, we successfully developed a radiolabeled probe targeting integrin α6
for the positron emission tomography (PET)/magnetic resonance (MR) imaging of pancreatic …

Objective Hepatocellular carcinoma (HCC) is a malignant tumor associated with high
morbidity and mortality rates. In many non-prostate solid tumors such as HCC, prostate …

While cross-sectional imaging with computed tomography (CT) and magnetic resonance
imaging is the primary method for diagnosing hepatocellular carcinoma (HCC), they provide …